☆ 4.5 Article

Bufalin reverses ABCB1-mediated resistance to docetaxel in breast cancer

HELIYON (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Add to Collection

Article Medicine, General & Internal

Bufalin suppresses ovarian cancer cell proliferation via EGFR pathway

Lei Dou et al.

Summary: Bufalin exerts antiproliferative effects on ovarian cancer cells through the EGFR/AKT/ERK signaling pathway, leading to inhibition of cell proliferation.

CHINESE MEDICAL JOURNAL (2022)

Add to Collection

Review Biochemistry & Molecular Biology

ABCB1/MDR1/P-gp employs an ATP-dependent twist-and-squeeze mechanism to export hydrophobic drugs

Atsushi Kodan et al.

Summary: ABCB1, also known as MDR1 or P-glycoprotein, plays a crucial role in exporting various hydrophobic compounds and serving as a protective physiological barrier in several organs. The mechanism involves an aromatic hydrophobic network triggering a conformational change in ABCB1, leading to a twist-and-squeeze motion that exports hydrophobic substrates directly to the extracellular space, distinct from other transporters.

FEBS LETTERS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Bufalin inhibits peritoneal dissemination of gastric cancer through endothelial nitric oxide synthase-mitogen-activated protein kinases signaling pathway

Dan Zou et al.

Summary: Bufalin has been shown to inhibit the proliferation, invasion, and migration of gastric cancer cells by targeting endothelial nitric oxide synthase (NOS3) and the mitogen-activated protein kinase (MAPK) signaling pathway, ultimately suppressing peritoneal dissemination. NOS3 was identified as a potential therapeutic target and prognostic biomarker for gastric cancer, providing support for the use of bufalin intraperitoneal perfusion in treating peritoneal dissemination.

FASEB JOURNAL (2021)

Add to Collection

Review Pharmacology & Pharmacy

Jadomycins: A potential chemotherapy for multi-drug resistant metastatic breast cancer

Esther P. Bonitto et al.

Summary: Breast cancer is one of the most deadly cancers in women globally, and some drug-resistant breast cancer cells are unresponsive to current treatments. Research shows that jadomycins may be a new therapy with cytotoxic effects on multi-drug resistant breast cancer cells.

PHARMACOLOGY RESEARCH & PERSPECTIVES (2021)

Add to Collection

Article Biochemistry & Molecular Biology

In vivo FRET analyses reveal a role of ATP hydrolysis?associated conformational changes in human P-glycoprotein

Ryota Futamata et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Add to Collection

Review Plant Sciences

Metabolites from Bufo gargarizans (Cantor, 1842): A review of traditional uses, pharmacological activity, toxicity and quality control

Xiang Zhan et al.

JOURNAL OF ETHNOPHARMACOLOGY (2020)

Add to Collection

Article Oncology

Breast Cancer: 45 Years of Research and Progress

Gabriel N. Hortobagyi

JOURNAL OF CLINICAL ONCOLOGY (2020)

Add to Collection

Review Multidisciplinary Sciences

A view on drug resistance in cancer

Neil Vasan et al.

NATURE (2019)

Add to Collection

Article Oncology

Bufalin inhibits human breast cancer tumorigenesis by inducing cell death through the ROS-mediated RIP1/RIP3/PARP-1 pathways

Yanlan Li et al.

CARCINOGENESIS (2018)

Add to Collection

Article Multidisciplinary Sciences

Molecular structure of human P-glycoprotein in the ATP-bound, outward-facing conformation

Youngjin Kim et al.

SCIENCE (2018)

Add to Collection

Article

Bufalin inhibits gastric cancer invasion and metastasis by down-regulating Wnt/ASCL2 expression

Jie Wang et al.

Oncotarget (2018)

Add to Collection

Article Oncology

Bufalin reverses acquired drug resistance by inhibiting stemness in colorectal cancer cells

Jian Sun et al.

ONCOLOGY REPORTS (2017)

Add to Collection

Article Oncology

Bufalin reverses ABCB1-mediated drug resistance in colorectal cancer

Ze-Ting Yuan et al.

ONCOTARGET (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Inhibition of SRC-3 enhances sensitivity of human cancer cells to histone deacetylase inhibitors

Zhengzhi Zou et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)

Add to Collection

Letter Biochemistry & Molecular Biology

The in vivo antitumor activity of cardiac glycosides in mice xenografted with human cancer cells is probably an experimental artifact

J. M. Calderon-Montano et al.

ONCOGENE (2014)

Add to Collection

Article Oncology

Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells

Wei Gu et al.

ONCOLOGY REPORTS (2014)

Add to Collection

Article Biochemistry & Molecular Biology

Refined structures of mouse P-glycoprotein

Jingzhi Li et al.

PROTEIN SCIENCE (2014)

Add to Collection

Article Oncology

Triple-Negative Breast Cancer: An Unmet Medical Need

Clifford A. Hudis et al.

ONCOLOGIST (2011)

Add to Collection

Article Oncology

Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic Manipulation

R. Z. Yusuf et al.

CURRENT CANCER DRUG TARGETS (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.